Építés alatt – nem éles oldal
Belépés

1481 open Prosztatarák trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Egyesült Államok658
Kína252
Kanada129
Franciaország109
Egyesült Királyság105
All other countries

The same trial often runs in several countries

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) has 6 sites in Olaszország and runs in 39 countries. If a site near you is full, another one may still take people.

See A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) in all 39 countries
Építés alatt, nem éles – Prosztatarák: vizsgálatok itt: Olaszország – Frontlight Research